Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Scenesse wins approval in U.S. for erythropoietic protoporphyria

Oct. 9, 2019

Dermavant initiates phase IIa study of cerdulatinib gel in vitiligo

Oct. 8, 2019

NKTR-358 begins new phase Ib studies in psoriasis and atopic dermatitis

Oct. 8, 2019

FDA approves Aklief cream for topical treatment of acne

Oct. 7, 2019

Shire Human Genetic Therapies presents new kallikrein B inhibitors

Oct. 7, 2019

Cabaletta Bio receives FDA IND clearance to initiate first-in-human study of DSG3-CAART

Oct. 2, 2019

AnaptysBio reports phase II interim data on ANB-019 in generalized pustular psoriasis

Oct. 1, 2019

Pfizer announces topline results from pivotal JADE MONO-2 study of abrocitinib

Sep. 30, 2019

First patient dosed in phase III TRuE-V clinical trial program of ruxolitinib cream

Sep. 26, 2019

Galapagos initiates phase I trial with GLPG-3970

Sep. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...